Skip to main content
ConductScienceScienceDex

Carmela R Abraham

NIH Rank #12956
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1860130Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$1.2M
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#12,956
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Carmela R Abraham. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Carmela R Abraham as a PI. Multi-PI records show the full award amount for context.

  • 1R44AG091827-01R44
    AD04 disease-modifying drug for Alzheimer's - preclinical and IND-enabling studies
    Advantage Therapeutics, Inc
    $1.2M
    award amount

Award organization

Organizations that administered FY2025 awards listing Carmela R Abraham as a PI.

FY2025 award administered by Advantage Therapeutics, Inc (FL).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Advantage Therapeutics, Inc
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2026
    $2M Cumulative Funding
  5. 2026
    Entered Top 50% Nationally
    Ranked #5684

Explore further

Find collaborators for Carmela R Abraham

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →